Literature DB >> 6174673

Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen.

J R Klein, D H Raulet, M S Pasternack, M J Bevan.   

Abstract

Interferon (IFN) was found to be secreted by cloned lines of murine cytotoxic T lymphocytes in response to mitogenic or antigen specific stimulation. The IFN produced was shown to be of the immune type based on its sensitivity to pH 2.0 and on the ability of an antiserum to immune IFN to neutralize the antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174673      PMCID: PMC2186637          DOI: 10.1084/jem.155.4.1198

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  On the varied biologic effects of interferon.

Authors:  I Gresser
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

2.  Interferons and the immune system.

Authors:  B R Bloom
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

3.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

4.  Interferon production in the murine mixed lymphocyte culture. I. Interferon production caused by differences in the H-2 K and H-2 D region but not by differences in the I region or the M locus.

Authors:  H Kirchner; R Zawatzky; V Schirrmacher
Journal:  Eur J Immunol       Date:  1979-01       Impact factor: 5.532

5.  Interferon production by human and murine lymphocytes in response to alloantigens.

Authors:  B Perussia; L Mangoni; H D Engers; G Trinchieri
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

6.  Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.

Authors:  A Marshak-Rothstein; P Fink; T Gridley; D H Raulet; M J Bevan; M L Gefter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

7.  Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis.

Authors:  T R Hünig; M J Bevan
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

8.  Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.

Authors:  A L Glasebrook; F W Fitch
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

9.  Concanavalin A-inducible, interleukin-2-producing T cell hybridoma.

Authors:  L Harwell; B Skidmore; P Marrack; J Kappler
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus.

Authors:  F A Ennis; A Meager
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  25 in total

1.  The distribution and possible function of gamma interferon-immunoreactive cells in normal endometrium and myometrium.

Authors:  C J Stewart; M A Farquharson; A K Foulis
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.

Authors:  H H Nguyen; F W van Ginkel; H L Vu; M J Novak; J R McGhee; J Mestecky
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Control of immune interferon release by cytotoxic T-cell clones specific for influenza.

Authors:  P M Taylor; D C Wraith; B A Askonas
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

4.  Establishment and characterization of a T-cell line specific for Rickettsia tsutsugamushi.

Authors:  K Kodama; S Kawamura; M Yasukawa; Y Kobayashi
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

5.  Isolation and partial characterization of concanavalin A receptors on cloned cytotoxic T lymphocytes.

Authors:  M V Sitkovsky; M S Pasternack; J P Lugo; J R Klein; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.

Authors:  Victor C Huber; Raelene M McKeon; Martha N Brackin; Laura A Miller; Rachael Keating; Scott A Brown; Natalia Makarova; Daniel R Perez; Gene H Macdonald; Jonathan A McCullers
Journal:  Clin Vaccine Immunol       Date:  2006-09

7.  Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone.

Authors:  U D Staerz; M S Pasternack; J R Klein; J D Benedetto; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation.

Authors:  Yalin Ren; Peizeng Yang; Bing Li; Yang Gao; Hongyan Zhou; Xiangkun Huang; Lianxiang Zhu; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

10.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.